Zobrazeno 1 - 4
of 4
pro vyhledávání: ''
Autor:
Sibylle Koletzko, Lissy de Ridder, Gábor Veres, Johanna C. Escher, Zrinjka Mišak, Jorge Amil Dias, Sanja Kolaček, Gigi Veereman-Wauters, Jean-François Rahier, John Fell, Petter Malmborg
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 54(6), 830-837. Lippincott Williams & Wilkins
Combined immunosuppression by immunomodulators and biological therapy has become standard in the medical management of moderate-to-severe inflammatory bowel disease (IBD) because of clearly demonstrated efficacy. Clinical studies, registries, and cas
Autor:
Frans van der Heide, Arie Dijkstra, Frans A. Albersnagel, Rinse K. Weersma, Elise M. van der Logt, Gerard Dijkstra, Jan H. Kleibeuker, Klaas Nico Faber, Wim J. Sluiter
Publikováno v:
Inflammatory Bowel Diseases, 15(8), 1199-1207. LIPPINCOTT WILLIAMS & WILKINS
Background: Smoking is a remarkable risk factor for inflammatory bowel disease (IBD). aggravating Crohn's disease (CD) while having beneficial effects On Ulcerative colitis (UC). We Studied the effects of active and passive smoking in Dutch IBD patie
Autor:
M. N. Tanzi, Y. K. L. Koda, Maria Oliva-Hemker, Johanna C. Escher, David D. Moore, M. Dubinksy, Simon Murch, B. Sandhu, B. Warner, Hans Hildebrand, Jeong Kee Seo
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 47(2), 266-272. Lippincott Williams & Wilkins
Johns Hopkins University School of Medicine, Baltimore, MD, {Erasmus Medical Center–Sophia Children’s Hospital, Rotterdam, The Netherlands, {Children, Youth, and Women’s Health Service, Adelaide, Australia, §Cedars-Sinai Medical Center, David
Publikováno v:
Journal of Pediatric Gastroenterology and Nutrition, 36, 464-469. Lippincott Williams & Wilkins
Objectives: Treatment options for patients with Crohn disease (CD) have expanded, but the use of some of these options in pediatric patients remains controversial. The authors evaluate current trends in treatment and areas of consensus or controversy